Session date: 
01/07/2020 - 11:00am to 11:45am

Pharmacy Grand Rounds

The Curious Case of Asparaginase

  • ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
  • Session Type: Knowledge-based
  • CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
    • AAPA Category 1 CME Credits
    • ACPE
    • AMA PRA Category 1 Credits™
    • ANCC
  • Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)
MN-RO-AL-MN-459-MAYO LH

Interactive Video Conference Room(s): 
MN-RO-GO-19-101 BARRETTE LH

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

This presentation will discuss the mechanism of action and clinical uses of asparaginase. It will also compare and contrast asparaginase formulations and their roles in therapy. Finally, it will outline common toxicities associated with asparaginase and review possible management strategies.

At the conclusion of this knowledge-based CE session, participants should be able to:

  1. Describe clinical indications of asparaginase
  2. Review asparaginase formulations and their roles in therapy
  3. Discuss toxicities and management strategies of asparaginase therapy.

PDF icon Session Announcement

PDF icon Session Slides

FACULTY INFORMATION

Catherine E. DeFino, PharmDPicture of Catherine E. DeFino, PharmD
PGY2 Oncology Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Catherine earned a Doctor of Pharmacy degree from Drake University in Des Moines, IA and subsequently completed a PGY1 pediatric pharmacy residency at Mayo Clinic. She is one of the current PGY2 oncology residents and has interests in pediatric and adult hematology/oncology.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

  • Catherine E. DeFino, PharmD
    • Declares no financial relationships pertinent to this session
    • Declares off-label use of devices and medications will be discussed during this presentation, including:
      • Calasparagase pegol
      • Erwinia asparaginase
      • E. Coli asparaginase
      • Pegaspargase

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

  • Brenda Amaris
  • Mary Ellen Cordes, MS, APRN, CNC, NE-BC
  • Michael Huckabee, MPAS, PA-C, PhD
  • Wayne (Nick) Nicholson, MD, PharmD, BCPS
  • Garrett Schramm, PharmD, BCPS
  • Lee Skrupky, PharmD, BCPS
Presenter: 
Catherine E. DeFino, PharmD
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota